Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, P.R. China.
J Occup Health. 2011;53(4):250-7. doi: 10.1539/joh.10-0055-oa. Epub 2011 Jun 13.
To investigate the injury of cell tight junctions and change in actin level in the alveolus epithelial cells of the lung after perfluoroisobutylene (PFIB) exposure and the role of myosin light chain kinase (MLCK) in the injury.
Rats and mice were exposed to a sublethal dose of PFIB. The changes in tight junction zonula occludens-1 (ZO-1), actin and myosin light chain kinase (MLCK) were detected by immunofluorescence at 30 min, 1, 2, 4, 8, 16, 24, 48 and 72 h after PFIB exposure. The role of MLCK was analyzed by lung indices and the actin level.
The normal ZO-1 immunofluorescence density and those after PFIB exposure were 71.63, 39.41, 37.59, 35.71, 33.22, 31.34, 31.61, 24.51, 40.03 and 44.71 respectively, The normal actin immunofluorescence density and those after PFIB exposure were 31.82, 36.46, 36.57, 41.60, 40.95, 35.41, 30.69, 19.96, 29.30 and 33.00 respectively, The normal MLCK immunofluorescence density and those after PFIB exposure were 61.21, 50.87, 48.37, 43.65, 41.96, 35.44, 31.77, 30.85, 33.10 and 38.20 respectively. When the MLCK inhibitor ML-7 was given in advance, pulmonary edema and actin degradation were suppressed.
At an earlier stage, the increased permeability of the blood-air barrier after PFIB exposure is probably the result of injury of cell tight junctions that acts in concert with later changes in actin, resulting in an increase in permeability. MLCK could be a potential target for novel drug development for relief of acute lung injury.
研究全氟异丁烯(PFIB)暴露后肺泡上皮细胞紧密连接损伤和肌球蛋白轻链激酶(MLCK)的变化,以及 MLCK 在损伤中的作用。
用亚致死剂量的 PFIB 染毒大鼠和小鼠,用免疫荧光法检测紧密连接蛋白闭合蛋白-1(ZO-1)、肌动蛋白和 MLCK 在 PFIB 暴露后 30 min、1、2、4、8、16、24、48 和 72 h 的变化。通过肺指数和肌动蛋白水平分析 MLCK 的作用。
正常 ZO-1 免疫荧光密度分别为 71.63、39.41、37.59、35.71、33.22、31.34、31.61、24.51、40.03 和 44.71,正常肌动蛋白免疫荧光密度分别为 31.82、36.46、36.57、41.60、40.95、35.41、30.69、19.96、29.30 和 33.00,正常 MLCK 免疫荧光密度分别为 61.21、50.87、48.37、43.65、41.96、35.44、31.77、30.85、33.10 和 38.20。预先给予 MLCK 抑制剂 ML-7 后,肺水肿和肌动蛋白降解受到抑制。
PFIB 暴露后早期血-气屏障通透性增加可能是细胞紧密连接损伤的结果,与随后肌动蛋白的变化协同作用,导致通透性增加。MLCK 可能是急性肺损伤新型药物治疗的潜在靶点。